|Videos|April 22, 2022
Q&A: Oligonucleotide Synthesis in Process Development and Scale-Up
Author(s)Cytiva
Give a quick overview of the oligonucleotide market, what is happening. Cover the typical challenges with oligonucleotide synthesis in the process development phase and solutions for those. Key considerations when scaling up oligonucleotide synthesis
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
2
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
3
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
4
How Biopharma Navigates the 2026 Economic Shift
5